These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3311581)

  • 21. Mechanisms of bacterial superinfections in viral pneumonias.
    Jakab GJ
    Schweiz Med Wochenschr; 1985 Jan; 115(3):75-86. PubMed ID: 3883482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette smoking and respiratory tract infection.
    Marcy TW; Merrill WW
    Clin Chest Med; 1987 Sep; 8(3):381-91. PubMed ID: 3311582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial agents in the elderly.
    Weber S; Mawdsley E; Kaye D
    Infect Dis Clin North Am; 2009 Dec; 23(4):881-98, viii. PubMed ID: 19909889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary defense mechanisms.
    Toews GB
    Semin Respir Infect; 1993 Sep; 8(3):160-7. PubMed ID: 8016475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
    Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
    [No Abstract]   [Full Text] [Related]  

  • 28. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of extracellular bactericidal factors in pulmonary host defense.
    Coonrod JD
    Semin Respir Infect; 1986 Jun; 1(2):118-29. PubMed ID: 3317603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immunity and the lung: defense at the interface between host and environment.
    Zaas AK; Schwartz DA
    Trends Cardiovasc Med; 2005 Aug; 15(6):195-202. PubMed ID: 16182128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary host defenses and factors predisposing to lung infection.
    Mason CM; Nelson S
    Clin Chest Med; 2005 Mar; 26(1):11-7. PubMed ID: 15802161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Iatrogenic respiratory disease].
    Akoun G; Huchon G; Herson S
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):644-55. PubMed ID: 795339
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunohistochemistry.
    Eckert H
    Z Erkr Atmungsorgane; 1991; 176(2-3):128-30. PubMed ID: 1858412
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of environmental factors on the defense system of the respiratory tract].
    Taszakowski W; Dwornicki J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):763-5. PubMed ID: 1488369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary reactions to non-infective antigenic contaminants.
    Akoun G; Molina C
    Ann Med Interne (Paris); 1976 Apr; 127(4):295-307. PubMed ID: 138375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary host defenses.
    Twigg HL
    J Thorac Imaging; 1998 Oct; 13(4):221-33. PubMed ID: 9799131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary host defenses. Implications for therapy.
    Mason CM; Nelson S
    Clin Chest Med; 1999 Sep; 20(3):475-88, vii. PubMed ID: 10516897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host defense abnormalities predisposing the patient to infection.
    Peterson PK
    Am J Med; 1984 May; 76(5A):2-10. PubMed ID: 6372471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary host defenses and alcohol.
    Zhang P; Bagby GJ; Happel KI; Summer WR; Nelson S
    Front Biosci; 2002 May; 7():d1314-30. PubMed ID: 11991862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.